IvanRychlik Czech RepublicCharles University, Third Faculty of Medicine, Department of Internal Medicine

Institution

Day 1 - Sunday April 14, 2024

Time	Session

9 a.m. 10:30 a.m.	Hands on Big Data Mining for the Nephrologist in 2024 SK1001 HeatherAscani Chairperson ascanihk@med.umich.eduUnited StatesUniversity of Michigan KatherineTuttle Chairperson Katherine.Tuttle@providence.orgUnited StatesUniversity of Washington School of Medicine, Division of Nephrology MatthiasKretzler Chairperson kretzler@umich.eduUnited StatesUniversity of Michigan Looking for Data on Glomerular Diseases: How to Find the Treasures You Are Looking for With a Click of a Mouse VijiNair Speaker vijin@med.umich.eduUnited StatesUniversity of Michigan Open Science in an Open Community: Resources of the Kidney Precision Medicine Project for CKD and AKI MatthiasKretzler Speaker kretzler@umich.eduUnited StatesUniversity of Michigan The Future is Now: How to Mine Cells and Neighborhoods of the Kidney in Health and Disease JulioSaez-Rodriguez Speaker julio.saez@uni-heidelberg.deGermanyHeidelberg University Panel Discussion Hall C1	Population Health and Strategies to Protect the Fragile BKH01 EnriqueDorado Chairperson egdorado@gmail.comArgentinaInstituto de Investigaciones Médicas "A. Lanari". Universidad de Buenos Aires ShokoufehSavaj Chairperson ssavaj@hotmail.comIran Being Born Too Small: What a Nephrologist Should Know to Support Prevention of CKD in Future Generations DanieleTrevisanuto Speaker daniele.trevisanuto@unipd.itItalyUniversity Hospital of Padova, Italy Hypertensive Disorders of Pregnancy as a Means to Discover CKD Giorgina BarbaraPiccoli Speaker GBPICCOLI@YAHOO.ITFranceCentre Hospitalier Le Mans Managing Pregnancy with Advanced CKD in a Limited-resource Setting AlejandraOrozco Guillen Speaker ale_gaba@hotmail.comMexicoNational Institute of Perinatology, Nephrology dep Pre-eclampsia and its Differential Diagnosis: A Viewpoint from LMICs RashaShemies Speaker rashasamirtaha@gmail.comEgyptMansoura University Q and A Hall D
2:45 p.m. 3:30 p.m.	What is ongoing in CKDu around the world? - CKDU interactive discussions (ISN i3C) SPOT-06 ErangaWijewickrama Spotlight Chairperson erangasw@clinmed.cmb.ac.lkSri LankaFaculty of Medicine, University of Colombo Jose VicenteSanchez Polo Spotlight Chairperson visanpolo@gmail.comGuatemalaRenal Division Social Security Institute. Nephrology Residence Program Coordinator, San Carlos University School of Medicine. Latin-American Society Of Nephrology (SLANH) Magdalena Madero Spotlight Speaker madero.magdalena@gmail.comMexicoChief of Nephrology, Instituto Nacional de Cardiol VivekanandJha Spotlight Speaker vjha@georgeinstitute.org.inIndiaGeorge Institute for Global Health India NishanthaNanyakkara Spotlight Speaker nishantha4313@gmail.comSri Lanka Spotlight Stage 1 (exhibition hall)
4 p.m. 4:30 p.m.	Potential Role of Anti-CD38 Therapy in Autoimmune Kidney Diseases like Lupus Nephritis SPOT-07 BradRovin Spotlight Speaker rovin.1@osu.eduUnited StatesThe Ohio State University UptalPatel Spotlight Speaker uptal@hibio.comUnited States Spotlight Stage 1 (exhibition hall)
4:30 p.m. 5:30 p.m.	New Developments in CKD Epidemiology Research IK1001 MaartenTaal Chairperson maarten.taal1@nhs.netUnited KingdomUniversity of Nottingham RobertoPecoits Filho Chairperson roberto.pecoits@arborresearch.orgUnited StatesArbor Research Collaborative for Health Big Data Lab LAB-01 Patient-reported Outcome Measures: How Do Patients Experience CKD? AdeeraLevin Speaker alevin@providencehealth.bc.caCanadaUniversity of British Columbia and Providence Health Care Trial Simulation Using Observational Data AngeloKaraboyas Speaker angelo.karaboyas@arborresearch.orgUnited StatesArbor Research Collaborative for Health Using Routinely Collected Big Datasets for Clinical Research in CKD: Opportunities and Challenges DorotheaNitsch Speaker dorothea.nitsch@lshtm.ac.ukUnited KingdomLondon School of Hygiene & Tropical Medicine Q and A Hall C4

Day 2 - Monday April 15, 2024

Time	Session

11 a.m. 12 p.m.	Plenary Session 3: Generative AI Revolution in Medicine (Michal Rosen-Zvi, Israel) PL3 Jose VicenteSanchez Polo Chairperson visanpolo@gmail.comGuatemalaRenal Division Social Security Institute. Nephrology Residence Program Coordinator, San Carlos University School of Medicine. Latin-American Society Of Nephrology (SLANH) MegJardine Chairperson meg.jardine@sydney.edu.auAustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia Generative AI Revolution in Medicine MichalRosen-Zvi Speaker ROSEN@il.ibm.comIsraelhttps://research.ibm.com/ Acceptance Speech by Awardee (Schrier Award), with Tasnuva Sarah Kashem (UK) and Farnaz Nobi (Bangladesh) Mohammad Shakib Uz ZamanArefin Speaker shakib04@yahoo.comBangladesh Hall A
12:15 p.m. 1:15 p.m.	It WIN AlejandraOrozco Guillen Chairperson ale_gaba@hotmail.comMexicoNational Institute of Perinatology, Nephrology dep IvanRychlik Chairperson ivan.rychlik@fnkv.czCzech RepublicCharles University, Third Faculty of Medicine, Department of Internal Medicine Rita MarcelaFortunato Chairperson marcelafortunator@gmail.comArgentinaFundacion Favaloro University Hospital, Faculty of Medicine, University of Buenos Aires Women and UrmilaAnandh Speaker uanandh@gmail.comIndiaAmrita Hospitals, Faridabad, Delhi NCR Pregnancy and CKD LizLightstone Speaker l.lightstone@imperial.ac.ukUnited KingdomImperial College London Pregnancy and Transplantation SilviShah Speaker silvishah2108@gmail.comUnited StatesUniversity of Cincinnati, Ohio, United States Global and African Epidemiology, Management and Outcomes of CKD and dialysis in Men and Women: A Perspective on Gender Disparities RashaDarwish Speaker dr.rasha-darwish@hotmail.comEgyptKasr Aleiny medical school , Cairo University Q and A Hall C4
3 p.m. 4 p.m.	Treatment Goals for Severe Hyponatremia: A Debate on Current Guidelines Program LF1005 MitchellRosner Chairperson MHR9R@hscmail.mcc.virginia.eduUnited StatesUniveristy of Virginia Health Overview of Hyponatremia Angela Yee-MoonWang Speaker angela.wang@duke-nus.edu.sgSingaporeHong Kong/Singapore Pro: Current Guidelines are Appropriate HelbertRondon-Berrios Speaker rondonberriosh@upmc.eduUnited StatesUniversity of Pittsburgh School of Medicine Con: Current Guidelines are Too Conservative CarlosAyus Speaker carlosayus@yahoo.comUnited StatesUniversity of California Irvine Discussion Hall C3
4:30 p.m. 5:30 p.m.	Paraproteinemia and the Kidney CHAL05 CarolineLamarche Chairperson caroline.lamarche.1@umontreal.caCanadaUniversité de Montréal Gustavo CristianGreloni Chairperson gustavo.greloni@hospitalitaliano.org.arArgentina MGRS: Should All Forms Need Clonal Therapy? FrankBridoux Speaker f.bridoux@chu-poitiers.frFranceDepartment of Nephrology and French Reference Center for AL amyloidosis and MGRS, University Hospital, Poitiers, France Renal Amyloidosis: What Is New? Veronica Torres CostaSilva Speaker veronica.torres@hc.fm.usp.brBrazilSão Paulo State Cancer Institute - University of São Paulo Can We Perform a Transplant in Patients with Myeloma and Amyloidosis? SabineKaram Speaker sabinejkaram@gmail.comUnited StatesUniversity of Minnesota Q and A Hall A

Day 3 - Tuesday April 16, 2024

Time	Session

9 a.m. 10 a.m.	Type 2 Diabetes in Kidney Disease: Recent Updates and Best Practices for Detection and Treatment LF1002 DebasishBanerjee Chairperson dbanerje@sgul.ac.ukUnited KingdomSt George's University Hospital NHS Foundation Tr MegJardine Chairperson meg.jardine@sydney.edu.auAustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia Setting the Scene MegJardine Speaker meg.jardine@sydney.edu.auAustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia DM and CKD: Which Treatment Should I Use for Different Populations? KatherineTuttle Speaker Katherine.Tuttle@providence.orgUnited StatesUniversity of Washington School of Medicine, Division of Nephrology How to Design Studies on Answering Unanswered Questions VladoPerkovic Speaker vlado.perkovic@unsw.edu.auAustraliaUniversity of New South Wales, Sydney, Australia The Effect of SGLT2 Inhibitors in Patients with Chronic Kidney Disease, With or Without Type 2 Diabetes DavidWheeler Speaker d.wheeler@ucl.ac.ukUnited KingdomUniversity College London Q and A Hall C4

Time

Session

9 a.m.

10 a.m.

Type 2 Diabetes in Kidney Disease: Recent Updates and Best Practices for Detection and Treatment

LF1002

DebasishBanerjee Chairperson dbanerje@sgul.ac.ukUnited KingdomSt George's University Hospital NHS Foundation Tr

MegJardine Chairperson meg.jardine@sydney.edu.auAustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia

Setting the Scene

MegJardine Speaker meg.jardine@sydney.edu.auAustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia
DM and CKD: Which Treatment Should I Use for Different Populations?

KatherineTuttle Speaker Katherine.Tuttle@providence.orgUnited StatesUniversity of Washington School of Medicine, Division of Nephrology
How to Design Studies on Answering Unanswered Questions

VladoPerkovic Speaker vlado.perkovic@unsw.edu.auAustraliaUniversity of New South Wales, Sydney, Australia
The Effect of SGLT2 Inhibitors in Patients with Chronic Kidney Disease, With or Without Type 2 Diabetes

DavidWheeler Speaker d.wheeler@ucl.ac.ukUnited KingdomUniversity College London
Q and A

Hall C4